Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthofix Medical (OFIX) EBIT (2016 - 2025)

Orthofix Medical (OFIX) has disclosed EBIT for 16 consecutive years, with $494000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBIT fell 98.95% year-over-year to $494000.0, compared with a TTM value of -$81.4 million through Dec 2025, down 213.03%, and an annual FY2025 reading of -$81.4 million, down 213.03% over the prior year.
  • EBIT was $494000.0 for Q4 2025 at Orthofix Medical, up from -$17.0 million in the prior quarter.
  • Across five years, EBIT topped out at $89.6 million in Q4 2023 and bottomed at -$59.7 million in Q1 2023.
  • Average EBIT over 5 years is -$7.3 million, with a median of -$4.8 million recorded in 2021.
  • Peak annual rise in EBIT hit 6095.52% in 2023, while the deepest fall reached 1840.03% in 2023.
  • Year by year, EBIT stood at -$3.9 million in 2021, then skyrocketed by 61.42% to -$1.5 million in 2022, then soared by 6095.52% to $89.6 million in 2023, then crashed by 47.38% to $47.1 million in 2024, then tumbled by 98.95% to $494000.0 in 2025.
  • Business Quant data shows EBIT for OFIX at $494000.0 in Q4 2025, -$17.0 million in Q3 2025, and -$16.0 million in Q2 2025.